Topic Highlight
Copyright ©2014 Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. May 21, 2014; 20(19): 5567-5574
Published online May 21, 2014. doi: 10.3748/wjg.v20.i19.5567
Can Helicobacter pylori infection influence human reproduction?
Elena Moretti, Natale Figura, Giulia Collodel, Antonio Ponzetto
Elena Moretti, Giulia Collodel, Department of Molecular and Developmental Medicine, University of Siena, 53100 Siena, Italy
Natale Figura, Department of Medical, Surgical and Neurological Sciences, University of Siena and Policlinico S Maria alle Scotte, 53100 Siena, Italy
Antonio Ponzetto, Department of Internal Medicine, University of Torino, 10126 Torino, Italy
Author contributions: All authors contributed equally to design, write and revise critically the review and approved the final version to be published.
Correspondence to: Natale Figura, Professor, Department of Medical, Surgical and Neurological Sciences, University of Siena and Policlinico S Maria alle Scotte, Viale Mario Bracci 16, 53100 Siena, Italy. natale.figura@unisi.it
Telephone: +39-577-585463 Fax: +39-577-233446
Received: October 28, 2013
Revised: November 29, 2013
Accepted: January 14, 2014
Published online: May 21, 2014

Abstract

Helicobacter pylori (H. pylori) infection could be associated with extra-digestive diseases. Here, we report the evidences concerning the decrease in reproductive potential occurring in individuals infected by H. pylori, especially by strains expressing CagA. This infection is more prevalent in individuals with fertility disorders. Infected women have anti-H. pylori antibodies in cervical mucus and follicular fluid that may decrease sperm motility and cross react immunologically with spermatozoa, conceivably hampering the oocyte/sperm fusion. Infection by CagA positive organisms enhances the risk of preeclampsia, which is a main cause of foetus death. These findings are supported by the results of experimental infections of pregnant mice, which may cause reabsorption of a high number of foetuses and alter the balance between Th1 and Th2 cell response. Infected men have decreased sperm motility, viability and numbers of normally shaped sperm and augmented systemic levels of inflammatory cytokines, such as tumor necrosis factor-α, which may damage spermatozoa. In countries where parasitic infestation is endemic, detrimental effects of infection upon spermatozoa may not occur, because the immune response to parasites could determine a switch from a predominant Th1 type to Th2 type lymphocytes, with production of anti-inflammatory cytokines. In conclusion, the evidences gathered until now should be taken into consideration for future studies aiming to explore the possible role of H. pylori infection on human reproduction.

Key Words: Antigenic mimicry, Helicobacter pylori infection, Human sperm, Inflammatory cytokines, Preeclampsia, Reproductive disorders

Core tip: The evidences that Helicobacter pylori (H. pylori) infection may have a role in decreasing human reproductive potential are steadily increasing. Sperm quality of men infected by H. pylori strains expressing CagA is reduced. Infected women have specific antibodies in cervical mucus, which decrease sperm motility, as well as in follicular fluids, which may cross react with sperm. In women with polycystic ovary syndrome and preeclampsia the prevalence of H. pylori infection is increased. The putative pathogenic mechanisms that account for these observations include elevated inflammatory cytokine levels in infected individuals and phenomena of antigenic mimicry between bacterial antigens and human proteins.



INTRODUCTION

The bacterium Helicobacter pylori (H. pylori), a microaerophilic, Gram-negative and spiral-shaped organism, is a member and the type species of the genus Helicobacter and is specialised to infect humans at the level of the gastroduodenal tract[1]. Despite its small genome of only 1667 kb, its restricted niche and the expression of a small number of metabolic activities, H. pylori has been capable of setting up an efficacious adaptive evolutionary machinery due to the possession of particular virulence determinants[2].

The infection is commonly acquired during the infancy and the first contact of susceptible individuals with this organism results in an acute gastritis[3]. In most cases, the infection becomes chronic and lasts throughout the entire patients’ life. Bacterial factors, together with a remarkable local and systemic immune response, are substantial determinants of peptic ulceration and important factors for the development of gastric tumours (carcinoma and non-Hodgkin’s lymphoma associated with mucosal lymphoid tissue)[4-7]. Not all strains have the same virulence; those harbouring the insertion named cag pathogenicity island in their chromosome are endowed with an increased inflammatory and carcinogenetic potential[8]. The terminal gene of this insertion, the cagA gene, encodes for an immunodominant protein called CagA, which is considered a marker for the presence of cag in the organisms and that induces the production of serum antibodies detectable by simple serological tests.

The possible outcomes of H. pylori infection are numerous because they may not be restricted to the gastroduodenal tract. In the nineties, epidemiological studies suggested that H. pylori infection might be associated with extra-digestive diseases that may affect heart and vessels; soon afterwards, the list of disorders related to this infection steadily increased and now encompass skin, oropharynx and various systems, such as the endocrine, respiratory, haemopoietic, immune and central nervous systems etc.[9,10]. If we exclude iron deficiency anaemia and idiopathic thrombocytopenic purpura, for which the results of different studies are consistent, most investigations on associated diseases have been given contradictory results. It is however possible that many diseases escape this association because their signs and symptoms are overlooked most of the time[9,10]. The most common extra-digestive diseases associated with H. pylori infection are reported in Table 1. Rising evidences in the literature suggest that even the reproductive sphere seems to be negatively influenced by H. pylori infectious status. Thus, the aim of the present mini-review is to deal with the possible role of H. pylori infection in reducing the reproductive potential of both women and men.

Table 1 Most common extra-digestive diseases and syndromes associated with Helicobacter pylori infection.
Organ, region, systemAssociation
Haemopoietic system[51,52]Iron deficiency anemia, idiopathic thrombocytopenic purpura, extra-gastric mucosal lymphoid tissue lymphoma
Cardiovascular or vascular system[53-55]Atherosclerosis (coronary heart disease, strock, aneurism), migraine, idiopathic arrhythmia
Endocrine system[56,57]Autoimmune thyroid disorders, resistance to insulin/diabetes, post-prandial hypoglycemia
Respiratory system[57-59]Chronic obstructive pulmonary disease, bronchiectasis, asthma, chronic otitis media with effusion
Skin[60-64]Rosacea, primitive chronic urticaria, pruritus cutaneus, Sweet’s syndrome, angioedema, alopecia areata, prurigo nodularis, lichen planus
Eye[65,66]Glaucoma, blepharitis
Rheumatologic diseases[67-70]Systemic sclerosis, Raynaud’s syndrome, Sjögren syndrome, Behçet disease
Central nervous system[71-74]Parkinson’s and Alzheimer’s disease, Guillain-Barre syndrome, hepatic encephalopathy
Reproductive system[11-21]Reduced fertility
Miscellanea[75-78]Sudden infant death syndrome, hyperemesis gravidarum, halitosis, growth delay
H. PYLORI INFECTION AND FEMALE REPRODUCTION

The hypothesis that H. pylori infection might increase the risk of infertility in women was first considered by our group in 2002, when we reported an increased prevalence of H. pylori infection in female patients with fertility disorders respect to controls (44.8% vs 29.7%, P = 0.033)[11]. After a few years, such observation was supported by a Japanese retrospective survey including 204 female patients[12]; in this study, seropositivity for H. pylori infection in the group of women with idiopathic infertility was twice higher than in patients with one or more known causes of infertility (38.09% vs 20.2% respectively, OR = 2.16). In addition, the majority of infected patients had antibodies to H. pylori at significant titres in the follicular fluids, supporting our previous observation that specific antibodies were detected in all the six analyzed follicular fluids from infected women (and in no samples from five uninfected patients)[11]. Recently, anti-H. pylori antibodies have been detected in the cervical mucus of infected women with unexplained infertility[13] and these antibodies inhibited in vitro the sperm progression. It is likely that the presence of specific antibodies in the different districts of the female genital apparatus may have pathogenetic meaning, as they could interfere with sperm motility and sperm capacitation, a pivotal step required for acquiring fertilization ability. This immune cross reactivity could be explained on the basis of an antigenic mimicry between sperm and H. pylori antigens since we have shown the existence of a partial linear homology between H. pylori peptides and tubulin, an important constituent of sperm flagella[11], and some enzymes of glycolytic process and Krebs cycle[14], all putatively involved in sperm motility.

A further possible mechanism that may interfere with fertility could be based on an observation made by Kellerman and Hunter[15], who identified a receptor on the vitelline membrane of bovine oocytes that recognized the Fc fragment of immunoglobulin G; these authors hypothesize that the adhesion of IgG to this receptor could play a role in sperm/egg interaction. As follicular fluids of infected women contain antibodies against H. pylori, we may hypothesize that the surface of oocytes could bind IgG through the Fc fragments impairing the interaction of egg with spermatozoa; alternatively, the free Fab fragments of adhered IgG might react immunologically with spermatozoa, thus hampering fertilization. This immune reaction could take place for a putative mechanism of antigenic mimicry, as we showed that antibodies obtained by immunizing animals with H. pylori or present in serum samples and other fluids of infected individuals could cross-react with spermatozoa[11].

Even though the number of investigations is scanty, studies showing a role of H. pylori in the development of endocrinopathies[16] suggest that this infection may influence reproduction. One of the most common endocrine disorders causing infertility is polycystic ovary syndrome (PCOS) and recently, Yavasoglu et al[17] reported an increase prevalence of H. pylori seropositivity in women suffering from PCOS respect to controls (40% vs 20%, P = 0.007).

The interference of H. pylori infection with human reproduction may also occur after oocyte fertilization, especially in case of preeclampsia (PE), one of the main causes of foetal (and maternal) mortality and morbidity. PE affects 2%-7% of pregnant women in the western world and much more in underdeveloped nations; it is characterized by high blood pressure and significant proteinuria in previously healthy women, generally after the 20th wk of gestation[18]; coagulative disorders are also very common. Despite the exact pathogenic mechanisms of PE are still obscure, some researchers have hypothesized that this syndrome may be caused by infectious agents[19].

Following the observation that H. pylori infection may cause fetal intrauterine growth restriction among Australian women suffering from PE[20], Ponzetto et al[21] examined 47 consecutive women with PE for H. pylori infection and anti-CagA serum antibodies and observed an increased prevalence of the infection in patients respect to that in women with uncomplicated pregnancy enrolled as controls (51.0% vs 31.9%, P = 0.033, OR = 2.6). Interestingly enough, the vast majority of patients had serum antibodies to the CagA protein, while only a few controls were CagA seropositive (P < 0.001, OR = 26.0). The presence of H. pylori DNA was also explored in placenta samples by PCR, but in no case it was positive. The association of PE with H. pylori infection was confirmed by a Turkish study[22] whose results showed increased TNF-α and CRP levels in the blood of infected patients respect to controls (normotensive pregnant women); the CagA status was not verified. Later on, Cardaropoli et al[23] observed that CagA positive H. pylori infection exclusively caused or contributed to PE complicated by foetal growth retardation (FGR), but not to PE without foeto-placental impairment. The results of their study prompted them to consider PE complicated by FGR and “pure FGR” as different pathologies and to classify PE as placental (with feto-placental involvement) or maternal (without feto-placental impairment), both with early or late onsets.

Now, it is well known that PE is a disease in which the systemic indices of inflammation are increased, together with elevated blood pressure and significant proteinuria[24]. The reasons of biological plausibility that link H. pylori infection to PE development are all fulfilled: acute phase reactants, such as CRP and polymorphs, are increased either in H. pylori infection and PE[22]; similarly, levels of pro-inflammatory cytokines, such as IL-6, macrophage migration inhibitory factor, TNF-αetc., and indices of a pro-coagulative status are augmented in both diseases[24-28]. Due to these observations, it is possible that PE can be associated with CagA positive H. pylori infection: strains expressing such immunodominant antigen are endowed with an increased inflammatory potential and infections caused by these organisms may contribute to the development of many digestive and extra-digestive diseases based on inflammation. Along infections by CagA positive H. pylori organisms, many vasoactive substances and cellular mediators, such as TNF-α and other cytokines, are produced locally in response to the infection and may diffuse in the bloodstream; in addition, chemokines may also be secreted systemically by immunocytes stimulated during the gastric circulation. All these phenomena may promote an inflammatory response in organs distant from the stomach.

The putative role of infection by H. pylori harbouring cagA in the development of PE has been suggested also by a recent study of Franceschi et al[29]. They started from a double order of observations: (1) endothelial dysfunctions may damage trophoblasts and are known to play a key role in the development of PE; and (2) anti-CagA antibodies may recognize immunologically antigens expressed by endothelial cells[30]. Since trophoblast cells have an endothelial origin, these researchers verified whether anti-CagA antibodies might also recognize antigens present on the surface of trophoblasts. This hypothesis was confirmed, as anti-CagA antibodies cross-reacted with β-actin of cytotrophoblast cells, whose invasiveness ability was diminished[29].

The risk of PE after intra-cytoplasmic sperm injection (ICSI) following oocyte donation is particularly high (up to 30%). Also the possibility of abortion is relatively increased after ICSI. The results of a recent Iranian study showed that precocious abortions after ICSI occurred far more frequently in women infected by CagA positive H. pylori strains[31]: 150 infertile women underwent ICSI and serological diagnosis of H. pylori infection; 58 patients were infected and 92 women were not. Interestingly, six out of seven infected women seropositive for CagA presented spontaneous abortion, vs only one out of 16 infected women seronegative for CagA (P = 0.0004, OR = 90.0, Fisher exact test). Despite this difference is highly significant, the infection by itself did not seem to affect the pregnancy rates: 23/58 infected women (39.6%) vs 27/92 uninfected patients (29.3%) became pregnant (P = 0.26).

The meaning of such observations is supported by the results of a study performed in animals experimentally infected. Female CD1 mice were infected before mating with a type I H. pylori strain (the cytotoxic and cagA positive H. pylori strain SPM326), isolated by one of our group (NF) from a patient with moderate, non-active, non-atrophic chronic gastritis. Afterwards, the animals were evaluated throughout the pregnancy for embryo/foetus characteristics and histopathological changes of the endometrium[32]. The endometrial lining of infected animals presented lymphocyte infiltration, epithelial transcytosis and cellular necrosis; the uterine glands showed loss of architecture and infiltration of inflammatory cells within the lamina propria. These pathological phenomena were accompanied by macrophage activation, increased endometrial infiltration of CD4+ and CD8+ lymphocytes and augmented expression of interferon-γ and major histocompatibility class II complex. Syncytiotrophoblastic cells of infected mice showed a substantial decrease of annexin V levels. Even more important were the observations that infected mice showed significantly increased numbers of resorbed foetuses and that the foetal weights were lower than those of non-infected controls. It is well known that H. pylori infection induces preferentially a Th1-type cell response[33]. Thus, the prevalent hypothesis explaining these findings is that, in infected pregnant mice, the immune response triggered by H. pylori infection could modify the natural immunosuppressive mechanisms of pregnancy by altering the systemic Th1/Th2 cell balance. The increased foetal resorption and the reduced foetal weight observed in infected mice could be related to a diminished expression of annexin V in syncytiotrophoblastic cells, since the loss of this molecule has been reported to be associated with placental disorders, including foetal resorption[34]. Should the results of future clinical studies confirm these findings, it would be reasonable to determine the H. pylori and the CagA status of women that desire to get pregnant.

H. PYLORI INFECTION AND MALE REPRODUCTION

Spermatozoa are the only flagellated human cells; sperm flagella may therefore share a linear homology with the bacterial flagella because structures with the same function are generally conserved during evolution. This idea prompted us to investigate the possible role of H. pylori in determining alterations of the male reproductive sphere. We found that the prevalence of H. pylori infection in men with fertility problems was higher than in controls (50.8% vs 36.1%, P = 0.003, OR = 1.83); we also detected anti-H. pylori antibodies in seminal plasma of 58% of infected men and in no samples of 11 seronegative patients. Immunocytochemical studies highlighted that anti-H. pylori hyperimmune sera, as well as serum samples from infected men, reacted immunologically with the flagellum (particularly rich in tubulin) and the equatorial segment of human ejaculated spermatozoa[11]. In addition, a partial linear homology was observed between human tubulin, the main constituent of sperm flagellum, and H. pylori proteins (flagellin, CagA and VacA), suggesting that mechanisms of antigenic mimicry may stimulate cross-reactive antibodies.

Further investigations, carried out in a group of idiopathic infertile patients, showed that infected men, especially those with serum antibodies to CagA, showed reduced sperm motility and a greater number of necrotic and apoptotic sperm in their ejaculates[25]. Concomitantly, increased systemic levels of tumour necrosis factor-alpha (TNF-α), a proinflammatory cytokine that may cause sperm damage, were observed in the group of idiopathic infertile males infected by H. pylori strains expressing CagA.

The influence of H. pylori strains expressing CagA on semen quality was further explored in a very recent study in which we examined 87 infected males for the possible relationship between infection by CagA positive H. pylori strains and sperm parameters evaluated following WHO guidelines[35]. In the CagA positive subjects, sperm motility (18% vs 32%, P < 0.01), sperm vitality (35% vs 48%, P < 0.01) and the percentage of sperm with normal morphology (18% vs 22%, P < 0.05) were significantly reduced compared with those measured in the CagA negative infected subjects[14].

In addition we recently observed that this infection may influence the semen concentrations of some hormones such as ghrelin and obestatin, peptides encoded by the same gene, mainly produced by the stomach and involved in energy balance and reproduction[36]. The relationship between this hormone and H. pylori infection resides in the fact that most circulating ghrelin is produced in the gastric oxyntic area and that ghrelin levels may decrease in patients infected by strains expressing CagA as result of mucosal atrophy[37]. Recently, both peptides were detected in human semen[38,39] at increased concentrations respect to serum levels. Afterwards, we detected significantly augmented ghrelin levels in the semen of patients infected by H. pylori strains expressing CagA, and we considered this finding as a possible response to a negative effect of infection upon the semen quality[40]. Also obestatin semen concentrations were increased in this kind of patients, but in non-significant manner.

There are only a limited number of studies on this subject. Should the reported results be confirmed by conclusions of other investigations, we believe that physicians should consider the eventuality of routinely testing men, who suffer from idiopathic fertility disorders, for H. pylori infection and the CagA status.

WHY IS THE BIRTH RATE STEADILY INCREASING IN THE DEVELOPING COUNTRIES? THE AFRICAN ENIGMA

Assuming that the infection increases the risk of infertility, why is the birth rate steadily increasing in the developing countries, where almost everyone is infected by H. pylori? The answer may be part of the paradox called “African enigma”[41]. Gastric H. pylori infection is common, almost ubiquitous in Africa, but the pattern of infection, age of acquisition, environmental, dietary, and genetic influences are different from those in West Countries. These different features may alter the pathological role and clinical relevance of the organism in Africa, where, apart from gastritis, there is no established correlation between H. pylori infection and upper gastrointestinal disease. These divergences could be applied to the possible consequences of infection upon the reproductive sphere in developing countries. Mitchell et al[42] provided evidence that the host immune response to H. pylori infection in an African population differs from that observed in subjects living in developed countries; for instance, IgG1/IgG2 predominant response was observed in 81% of Sowetan adults and 90% of children compared with 4.7% of Australians and 4.4% of Germans.

The most convincing explanation of such apparent paradox comes from the study of the cell immune response to H. pylori infection in Western population (who have a very low rate of parasitic infestation) and in developing countries (where parasitic infestation is very common). The results of these studies have shown that co-infestation with parasites might alter the expression of the infection and result in a change in the pattern and/or severity of gastritis and thus in the prevalence and clinical outcome of disease. One constant consequence of H. pylori infection is the production of reactive oxygen species (ROS) by immunocytes infiltrating the gastric mucosa and circulating in the blood stream. If the infecting strains contain the cagA gene, particularly high amounts of ROS are generated. In an Egyptian study, it was shown that patients with a concurrent Schistosoma mansoni infestation had a modified inflammatory response to gastric H. pylori infection while ROS were dramatically reduced. The authors concluded that co-infestation with helminths may have a protective effect against the possible progression of H. pylori-induced gastritis towards gastric carcinoma[43]. Due to the high prevalence of parasitic infestation in developing countries, differences with Western population may also be extended to the cell immune response to H. pylori infection. In Western population, H. pylori causes a predominant and prolonged Th1 type response that is unable to eliminate the organism, may damages the mucosa and lead to gastroduodenal disease and systemic, inflammatory-mediated involvement[44,45]. Data from Mitchell and colleagues have supported the hypothesis that a Th2 polarised response to H. pylori is more common in Africa while a Th1 polarised response is more common in Europe and Australia[42]. Such a particular behaviour is also common in underdeveloped Centre American Countries: the results of a study performed in Colombian children suggest that intestinal helminthiasis promotes Th2-polarizing responses to H. pylori, may reduce the mucosal damage caused by inflammation and therefore affect the progression of gastritis to gastric atrophy, dysplasia, and cancer[46]. Another study confirmed that in Africa H. pylori infection does not appear to elicit the range of host mucosal response commonly observed in developed countries: despite the high ratio of anti-CagA seropositivity among infected Gambian adults (93%), histological findings of gastric atrophy and intestinal metaplasia were very rare; in addition, there was no difference in mucosal response between CagA positive and CagA negative individuals[47].

The observation that helminths induce a more polarized Th2 response and theoretically would help decrease the histological lesions induced by H. pylori infection, has been confirmed in the mouse animal model: co-infestation with helminths and H. felis resulted in reduced epithelial damage and atrophy compared with animals infected exclusively with H. felis[48]; in particular, the Th-cell immune response switched from a predominantly Th1-type to a Th2-type response, which is characterized by the release of the non-inflammatory cytokines IL-4, IL-5 and IL-10[49,50]. In case of co-infestation with helminths, in areas where parasitosis is endemic, such as Africa and Central America, Th2 response may protect the gastric mucosa from the damage caused by the microorganisms and determine the releasing of anti-inflammatory cytokines, which might partially protect the gastric mucosa and concur to explain the African enigma[44]. These observations could also be applied to the reproductive sphere. In other terms, the production of anti-inflammatory cytokines and a predominant Th2 response, both triggered by parasitic infestation could also protect various organs and fluids, in addition to the gastric epithelium, from the damage caused by the presence of H. pylori organisms.

CONCLUSION

There are evidences that H. pylori infection, especially by strains expressing CagA, may influence negatively the human reproductive potential. It is generally accepted that one of the mechanisms that may explain the association of H. pylori infection with extra-digestive diseases, could reside in the overproduction of inflammatory cytokines, which is a distinctive feature of strains expressing CagA. It is also assumed that the effects of local inflammation may not be confined to the digestive tract, but they can spread to involve extra-gastroduodenal organs and systems. Antigenic mimicry between CagA and other bacterial antigens and human peptides could also play a relevant role. Before reproductive disorders could be considered an additional manifestation of extra-digestive diseases associated with H. pylori infection, it is necessary to carry out other studies concerning the prevalence of H. pylori infection in patients and controls, and in particular to perform study dealing with evaluation of reproductive potential after eradication of H. pylori infection.

ACKNOWLEDGMENTS

We wish to thank Mr Roberto Faleri, Medicine Library, for his invaluable help with the references.

Footnotes

P- Reviewers: Lee YC, Rabelo-Goncalves EMA, Shih WL, Ulasoglu C, Youn HS S- Editor: Qi Y L- Editor: A E- Editor: Liu XM

References
1.  Goodwin CS, Worsley BW. The Helicobacter genus: The history of H. pylori and taxonomy of current species. Helicobacter pylori: Biology and Clinical Practice. Boca Raton FL: CRC Press 1993; 1-13.  [PubMed]  [DOI]
2.  Fraser CM, Casjens S, Huang WM, Sutton GG, Clayton R, Lathigra R, White O, Ketchum KA, Dodson R, Hickey EK. Genomic sequence of a Lyme disease spirochaete, Borrelia burgdorferi. Nature. 1997;390:580-586.  [PubMed]  [DOI]
3.  Sobala GM, Crabtree JE, Dixon MF, Schorah CJ, Taylor JD, Rathbone BJ, Heatley RV, Axon AT. Acute Helicobacter pylori infection: clinical features, local and systemic immune response, gastric mucosal histology, and gastric juice ascorbic acid concentrations. Gut. 1991;32:1415-1418.  [PubMed]  [DOI]
4.  Blaser MJ. Gastric Campylobacter-like organisms, gastritis, and peptic ulcer disease. Gastroenterology. 1987;93:371-383.  [PubMed]  [DOI]
5.  Graham DY. Campylobacter pylori and peptic ulcer disease. Gastroenterology. 1989;96:615-625.  [PubMed]  [DOI]
6.  Parsonnet J, Hansen S, Rodriguez L, Gelb AB, Warnke RA, Jellum E, Orentreich N, Vogelman JH, Friedman GD. Helicobacter pylori infection and gastric lymphoma. N Engl J Med. 1994;330:1267-1271.  [PubMed]  [DOI]
7.  Wotherspoon AC, Ortiz-Hidalgo C, Falzon MR, Isaacson PG. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet. 1991;338:1175-1176.  [PubMed]  [DOI]
8.  Noto JM, Peek RM. The Helicobacter pylori cag Pathogenicity Island. Methods Mol Biol. 2012;921:41-50.  [PubMed]  [DOI]
9.  Figura N, Franceschi F, Santucci A, Bernardini G, Gasbarrini G, Gasbarrini A. Extragastric manifestations of Helicobacter pylori infection. Helicobacter. 2010;15 Suppl 1:60-68.  [PubMed]  [DOI]
10.  Roubaud Baudron C, Franceschi F, Salles N, Gasbarrini A. Extragastric diseases and Helicobacter pylori. Helicobacter. 2013;18 Suppl 1:44-51.  [PubMed]  [DOI]
11.  Figura N, Piomboni P, Ponzetto A, Gambera L, Lenzi C, Vaira D, Peris C, Lotano MR, Gennari L, Bianciardi L. Helicobacter pylori infection and infertility. Eur J Gastroenterol Hepatol. 2002;14:663-669.  [PubMed]  [DOI]
12.  Kurotsuchi S, Ando H, Iwase A, Ishida Y, Hamajima N, Kikkawa F. The plausibility of Helicobacter pylori-related infertility in Japan. Fertil Steril. 2008;90:866-868.  [PubMed]  [DOI]
13.  Ambrosini G, Andrisani A, Fiore C, Faggian D, D’Antona D, Ragazzi E, Plebani M, Armanini D. Anti-Helicobacter pylori antibodies in cervical mucus: a new cause of infertility. Eur J Obstet Gynecol Reprod Biol. 2011;155:157-160.  [PubMed]  [DOI]
14.  Moretti E, Collodel G, Mazzi L, Campagna MS, Figura N. CagA-positive Helicobacter pylori infection and reduced sperm motility, vitality, and normal morphology. Dis Markers. 2013;35:229-234.  [PubMed]  [DOI]
15.  Kellerman SA, Hunter AG. Identification of a receptor on the vitelline membrane of bovine oocytes that recognizes bovine immunoglobulin G. J Dairy Sci. 1992;75:1443-1447.  [PubMed]  [DOI]
16.  Papamichael KX, Papaioannou G, Karga H, Roussos A, Mantzaris GJ. Helicobacter pylori infection and endocrine disorders: is there a link? World J Gastroenterol. 2009;15:2701-2707.  [PubMed]  [DOI]
17.  Yavasoglu I, Kucuk M, Cildag B, Arslan E, Gok M, Kafkas S. A novel association between polycystic ovary syndrome and Helicobacter pylori. Am J Med Sci. 2009;338:174-177.  [PubMed]  [DOI]
18.  Shenoy V, Kanasaki K, Kalluri R. Pre-eclampsia: connecting angiogenic and metabolic pathways. Trends Endocrinol Metab. 2010;21:529-536.  [PubMed]  [DOI]
19.  Rustveld LO, Kelsey SF, Sharma R. Association between maternal infections and preeclampsia: a systematic review of epidemiologic studies. Matern Child Health J. 2008;12:223-242.  [PubMed]  [DOI]
20.  Eslick GD, Yan P, Xia HH, Murray H, Spurrett B, Talley NJ. Foetal intrauterine growth restrictions with Helicobacter pylori infection. Aliment Pharmacol Ther. 2002;16:1677-1682.  [PubMed]  [DOI]
21.  Ponzetto A, Cardaropoli S, Piccoli E, Rolfo A, Gennero L, Kanduc D, Todros T. Pre-eclampsia is associated with Helicobacter pylori seropositivity in Italy. J Hypertens. 2006;24:2445-2449.  [PubMed]  [DOI]
22.  UstUn Y, Engin-UstUn Y, Ozkaplan E, Otlu B, Sait TekerekoGlu M. Association of Helicobacter pylori infection with systemic inflammation in preeclampsia. J Matern Fetal Neonatal Med. 2010;23:311-314.  [PubMed]  [DOI]
23.  Cardaropoli S, Rolfo A, Piazzese A, Ponzetto A, Todros T. Helicobacter pylori’s virulence and infection persistence define pre-eclampsia complicated by fetal growth retardation. World J Gastroenterol. 2011;17:5156-5165.  [PubMed]  [DOI]
24.  Pinheiro MB, Martins-Filho OA, Mota AP, Alpoim PN, Godoi LC, Silveira AC, Teixeira-Carvalho A, Gomes KB, Dusse LM. Severe preeclampsia goes along with a cytokine network disturbance towards a systemic inflammatory state. Cytokine. 2013;62:165-173.  [PubMed]  [DOI]
25.  Collodel G, Moretti E, Campagna MS, Capitani S, Lenzi C, Figura N. Infection by CagA-positive Helicobacter pylori strains may contribute to alter the sperm quality of men with fertility disorders and increase the systemic levels of TNF-alpha. Dig Dis Sci. 2010;55:94-100.  [PubMed]  [DOI]
26.  Perri F, Clemente R, Festa V, De Ambrosio CC, Quitadamo M, Fusillo M, Grossi E, Andriulli A. Serum tumour necrosis factor-alpha is increased in patients with Helicobacter pylori infection and CagA antibodies. Ital J Gastroenterol Hepatol. 1999;31:290-294.  [PubMed]  [DOI]
27.  Xia HH, Lam SK, Chan AO, Lin MC, Kung HF, Ogura K, Berg DE, Wong BC. Macrophage migration inhibitory factor stimulated by Helicobacter pylori increases proliferation of gastric epithelial cells. World J Gastroenterol. 2005;11:1946-1950.  [PubMed]  [DOI]
28.  Macey MG, Bevan S, Alam S, Verghese L, Agrawal S, Beski S, Thuraisingham R, MacCallum PK. Platelet activation and endogenous thrombin potential in pre-eclampsia. Thromb Res. 2010;125:e76-e81.  [PubMed]  [DOI]
29.  Franceschi F, Di Simone N, D’Ippolito S, Castellani R, Di Nicuolo F, Gasbarrini G, Yamaoka Y, Todros T, Scambia G, Gasbarrini A. Antibodies anti-CagA cross-react with trophoblast cells: a risk factor for pre-eclampsia? Helicobacter. 2012;17:426-434.  [PubMed]  [DOI]
30.  Franceschi F, Niccoli G, Ferrante G, Gasbarrini A, Baldi A, Candelli M, Feroce F, Saulnier N, Conte M, Roccarina D. CagA antigen of Helicobacter pylori and coronary instability: insight from a clinico-pathological study and a meta-analysis of 4241 cases. Atherosclerosis. 2009;202:535-542.  [PubMed]  [DOI]
31.  Hajishafiha M, Ghasemi-Rad M, Memari A, Naji S, Mladkova N, Saeedi V. Effect of Helicobacter pylori infection on pregnancy rates and early pregnancy loss after intracytoplasmic sperm injection. Int J Womens Health. 2011;3:329-335.  [PubMed]  [DOI]
32.  Rossi G, Romagnoli S, Lauretti L, Pancotto L, Taccini E, Rappuoli R, Del Giudice G, Ruggiero P. Helicobacter pylori infection negatively influences pregnancy outcome in a mouse model. Helicobacter. 2004;9:152-157.  [PubMed]  [DOI]
33.  D'Elios MM, Amedei A, Del Prete G. Helicobacter pylori antigen-specific T-cell responses at gastric level in chronic gastritis, peptic ulcer, gastric cancer and low-grade mucosa-associated lymphoid tissue (MALT) lymphoma. Microbes Infect. 2003;5:723-730.  [PubMed]  [DOI]
34.  Wang X, Campos B, Kaetzel MA, Dedman JR. Annexin V is critical in the maintenance of murine placental integrity. Am J Obstet Gynecol. 1999;180:1008-1016.  [PubMed]  [DOI]
35.  World Health Organization. WHO laboratory manual for the examination and processing of human semen. 5th ed. 2010, WHO Press, Geneva, Switzerland.  Available from: http://www.who.int/reproductivehealth/publications/infertility/9789241547789/en/.  [PubMed]  [DOI]
36.  Repaci A, Gambineri A, Pagotto U, Pasquali R. Ghrelin and reproductive disorders. Mol Cell Endocrinol. 2011;340:70-79.  [PubMed]  [DOI]
37.  Kawashima J, Ohno S, Sakurada T, Takabayashi H, Kudo M, Ro S, Kato S, Yakabi K. Circulating acylated ghrelin level decreases in accordance with the extent of atrophic gastritis. J Gastroenterol. 2009;44:1046-1054.  [PubMed]  [DOI]
38.  Panidis D, Goulis DG, Katsikis I, Koliakos G, Georgopoulos NA, Diamanti-Kandarakis E. Serum and seminal plasma ghrelin levels in men with normospermia and dyspermia. Gynecol Endocrinol. 2008;24:320-325.  [PubMed]  [DOI]
39.  Moretti E, Collodel G, Iacoponi F, Geminiani M, Pascarelli NA, Campagna S, Franci B, Figura N. Detection of obestatin in seminal plasma and its relationship with ghrelin and semen parameters. Fertil Steril. 2011;95:2303-2309.  [PubMed]  [DOI]
40.  Moretti E, Collodel G, Campagna MS, Franci MB, Iacoponi F, Mazzi L, Figura N. Influence of Helicobacter pylori infection on levels of ghrelin and obestatin in human semen. J Androl. 2012;33:938-943.  [PubMed]  [DOI]
41.  Holcombe C. Helicobacter pylori: the African enigma. Gut. 1992;33:429-431.  [PubMed]  [DOI]
42.  Mitchell HM, Ally R, Wadee A, Wiseman M, Segal I. Major differences in the IgG subclass response to Helicobacter pylori in the first and third worlds. Scand J Gastroenterol. 2002;37:517-522.  [PubMed]  [DOI]
43.  Elshal MF, Elsayed IH, El Kady IM, Badra G, El-Refaei A, El-Batanony M, Hendy OM. Role of concurrent S. mansoni infection in H. pylori-associated gastritis: a flow cytometric DNA-analysis and oxyradicals correlations. Clin Chim Acta. 2004;346:191-198.  [PubMed]  [DOI]
44.  D'Elios MM, Andersen LP, Del Prete G. Inflammation and host response. Curr Opin Gastroenterol. 1998;14:15-19.  [PubMed]  [DOI]
45.  Bamford KB, Fan X, Crowe SE, Leary JF, Gourley WK, Luthra GK, Brooks EG, Graham DY, Reyes VE, Ernst PB. Lymphocytes in the human gastric mucosa during Helicobacter pylori have a T helper cell 1 phenotype. Gastroenterology. 1998;114:482-492.  [PubMed]  [DOI]
46.  Whary MT, Sundina N, Bravo LE, Correa P, Quinones F, Caro F, Fox JG. Intestinal helminthiasis in Colombian children promotes a Th2 response to Helicobacter pylori: possible implications for gastric carcinogenesis. Cancer Epidemiol Biomarkers Prev. 2005;14:1464-1469.  [PubMed]  [DOI]
47.  Campbell DI, Warren BF, Thomas JE, Figura N, Telford JL, Sullivan PB. The African enigma: low prevalence of gastric atrophy, high prevalence of chronic inflammation in West African adults and children. Helicobacter. 2001;6:263-267.  [PubMed]  [DOI]
48.  Fox JG, Beck P, Dangler CA, Whary MT, Wang TC, Shi HN, Nagler-Anderson C. Concurrent enteric helminth infection modulates inflammation and gastric immune responses and reduces helicobacter-induced gastric atrophy. Nat Med. 2000;6:536-542.  [PubMed]  [DOI]
49.  Fox JG, Wang TC, Nagler-Anderson C. The African enigma: the parasite’s perspective. Gut. 2001;49:156-157.  [PubMed]  [DOI]
50.  Gordon D. Solving the African enigma: parasites may have their place. Gastroenterology. 2000;119:611.  [PubMed]  [DOI]
51.  Reinauer S, Megahed M, Goerz G, Ruzicka T, Borchard F, Susanto F, Reinauer H. Schönlein-Henoch purpura associated with gastric Helicobacter pylori infection. J Am Acad Dermatol. 1995;33:876-879.  [PubMed]  [DOI]
52.  Nishimura M, Miyajima S, Okada N. Salivary gland MALT lymphoma associated with Helicobacter pylori infection in a patient with Sjögren’s Syndrome. J Dermatol. 2000;27:450-452.  [PubMed]  [DOI]
53.  Manolakis A, Kapsoritakis AN, Potamianos SP. A review of the postulated mechanisms concerning the association of Helicobacter pylori with ischemic heart disease. Helicobacter. 2007;12:287-297.  [PubMed]  [DOI]
54.  Tunca A, Ardiçoğlu Y, Kargili A, Adam B. Migraine, Helicobacter pylori, and oxidative stress. Helicobacter. 2007;12:59-62.  [PubMed]  [DOI]
55.  Montenero AS, Mollichelli N, Zumbo F, Antonelli A, Dolci A, Barberis M, Sirolla C, Staine T, Fiocca L, Bruno N. Helicobacter pylori and atrial fibrillation: a possible pathogenic link. Heart. 2005;91:960-961.  [PubMed]  [DOI]
56.  Figura N, Di Cairano G, Lorè F, Guarino E, Gragnoli A, Cataldo D, Giannace R, Vaira D, Bianciardi L, Kristodhullu S. The infection by Helicobacter pylori strains expressing CagA is highly prevalent in women with autoimmune thyroid disorders. J Physiol Pharmacol. 1999;50:817-826.  [PubMed]  [DOI]
57.  Açbay O, Celik AF, Kadioğlu P, Göksel S, Gündoğdu S. Helicobacter pylori-induced gastritis may contribute to occurrence of postprandial symptomatic hypoglycemia. Dig Dis Sci. 1999;44:1837-1842.  [PubMed]  [DOI]
58.  Gencer M, Ceylan E, Yildiz Zeyrek F, Aksoy N. Helicobacter pylori seroprevalence in patients with chronic obstructive pulmonary disease and its relation to pulmonary function tests. Respiration. 2007;74:170-175.  [PubMed]  [DOI]
59.  Yilmaz MD, Aktepe O, Cetinkol Y, Altuntaş A. Does Helicobacter pylori have role in development of otitis media with effusion? Int J Pediatr Otorhinolaryngol. 2005;69:745-749.  [PubMed]  [DOI]
60.  Zandi S, Shamsadini S, Zahedi MJ, Hyatbaksh M. Helicobacter pylori and rosacea. East Mediterr Health J. 2003;9:167-171.  [PubMed]  [DOI]
61.  Wedi B, Kapp A. Helicobacter pylori infection and skin diseases. J Physiol Pharmacol. 1999;50:753-776.  [PubMed]  [DOI]
62.  Campuzano-Maya G. Cure of alopecia areata after eradication of Helicobacter pylori: a new association? World J Gastroenterol. 2011;17:3165-3170.  [PubMed]  [DOI]
63.  Accioly-Filho LW, Nogueira A, Ramos-e-Silva M. Prurigo nodularis of Hyde: an update. J Eur Acad Dermatol Venereol. 2000;14:75-82.  [PubMed]  [DOI]
64.  Izol B, Karabulut AA, Biyikoglu I, Gonultas M, Eksioglu M. Investigation of upper gastrointestinal tract involvement and H. pylori presence in lichen planus: a case-controlled study with endoscopic and histopathological findings. Int J Dermatol. 2010;49:1121-1126.  [PubMed]  [DOI]
65.  Kountouras J, Mylopoulos N, Chatzopoulos D, Zavos C, Boura P, Konstas AG, Venizelos J. Eradication of Helicobacter pylori may be beneficial in the management of chronic open-angle glaucoma. Arch Intern Med. 2002;162:1237-1244.  [PubMed]  [DOI]
66.  Saccà SC, Pascotto A, Venturino GM, Prigione G, Mastromarino A, Baldi F, Bilardi C, Savarino V, Brusati C, Rebora A. Prevalence and treatment of Helicobacter pylori in patients with blepharitis. Invest Ophthalmol Vis Sci. 2006;47:501-508.  [PubMed]  [DOI]
67.  Farina G, Rosato E, Francia C, Proietti M, Donato G, Ammendolea C, Pisarri S, Salsano F. High incidence of Helicobacter pylori infection in patients with systemic sclerosis: association with Sicca Syndrome. Int J Immunopathol Pharmacol. 2001;14:81-85.  [PubMed]  [DOI]
68.  Gasbarrini A, Serricchio M, Tondi P, De Luca A, Franceschi F, Ojetti V V, Pola R, Dal Lago A, Flore R, Santoliquido A. Raynaud's Phenomenon and Helicobacter Pylori Infection. Int J Angiol. 1998;7:307-309.  [PubMed]  [DOI]
69.  Figura N, Giordano N, Burroni D, Macchia G, Vindigni C, Gennari C, Bayeli P. Sjögren syndrome and Helicobacter pylori infection. Eur J Gastroenterol Hepatol. 1994;6:321-322.  [PubMed]  [DOI]
70.  Albanidou-Farmaki E, Giannoulis L, Markopoulos A, Fotiades S, Aggouridaki X, Farmakis K, Papanayotou P. Outcome following treatment for Helicobacter pylori in patients with recurrent aphthous stomatitis. Oral Dis. 2005;11:22-26.  [PubMed]  [DOI]
71.  Altschuler E. Gastric Helicobacter pylori infection as a cause of idiopathic Parkinson disease and non-arteric anterior optic ischemic neuropathy. Med Hypotheses. 1996;47:413-414.  [PubMed]  [DOI]
72.  Kountouras J, Tsolaki M, Gavalas E, Boziki M, Zavos C, Karatzoglou P, Chatzopoulos D, Venizelos I. Relationship between Helicobacter pylori infection and Alzheimer disease. Neurology. 2006;66:938-940.  [PubMed]  [DOI]
73.  Ghabaee M, Ghanbarian D, Brujeni GN, Bokaei S, Siavoshi F, Gharibzadeh S. Could Helicobacter pylori play an important role in axonal type of Guillain-Barré syndrome pathogenesis? Clin Neurol Neurosurg. 2010;112:193-198.  [PubMed]  [DOI]
74.  Abdel-Hady H, Zaki A, Badra G, Lotfy M, Selmi C, Giorgini A, El-Sayed M, Badr R. Helicobacter pylori infection in hepatic encephalopathy: Relationship to plasma endotoxins and blood ammonia. Hepatol Res. 2007;37:1026-1033.  [PubMed]  [DOI]
75.  Stray-Pedersen A, Vege A, Rognum TO. Helicobacter pylori antigen in stool is associated with SIDS and sudden infant deaths due to infectious disease. Pediatr Res. 2008;64:405-410.  [PubMed]  [DOI]
76.  Golberg D, Szilagyi A, Graves L. Hyperemesis gravidarum and Helicobacter pylori infection: a systematic review. Obstet Gynecol. 2007;110:695-703.  [PubMed]  [DOI]
77.  Adler I, Denninghoff VC, Alvarez MI, Avagnina A, Yoshida R, Elsner B. Helicobacter pylori associated with glossitis and halitosis. Helicobacter. 2005;10:312-317.  [PubMed]  [DOI]
78.  Patel P, Mendall MA, Khulusi S, Northfield TC, Strachan DP. Helicobacter pylori infection in childhood: risk factors and effect on growth. BMJ. 1994;309:1119-1123.  [PubMed]  [DOI]